SCHEMBL492196

SCHEMBL492196

NC(=O)C[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL5043231 0.97
Hydrochloric Acid SCHEMBL28741632 0.97
SCHEMBL9733202 0.78
SCHEMBL3811251 0.73 MEN1 (0.41)
SCHEMBL9830446 0.73
SCHEMBL3650467 0.73
SCHEMBL28356166 0.73
Nitroacetic Acid SCHEMBL153563 0.71
SCHEMBL9229619 0.71
SCHEMBL961615 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107082450-B A kind of Ag0.33V2O5The preparation method of material 中国工程物理研究院流体物理研究所 2018-07-31 CN claimed
CN-107098850-A A kind of method for synthesizing the piperidones of 1 methyl, 3 nitro, 4 phenyl 2,6 2 西安近代化学研究所 2017-08-29 CN claimed
CN-1083447-C Process for preparation of benzothiazolone compounds ASTRA PHARMA PROD (SE) 2002-04-24 CN claimed
CN-1248252-A Preparation method of benzothiazolone compound ASTRA PHARMA PROD (GB) 2000-03-22 CN claimed
EP-0970064-A1 PROCESS FOR THE PREPARATION OF BENZOTHIAZOLONE COMPOUNDS Astra Pharmaceuticals Limited (GB) 2000-01-12 EP claimed
WO-1998038180-A1 PROCESS FOR THE PREPARATION OF BENZOTHIAZOLONE COMPOUNDS ASTRA PHARMACEUTICALS LTD. (GB) 1998-09-03 WO claimed
EP-3743068-B1 COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS EXELIXIS INC (US) 2026-04-29 EP disclosed
US-12440496-B2 Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes MERCK SHARP & DOHME LLC (US) 2025-10-14 US disclosed
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 EP disclosed
US-20250230157-A1 AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS RAPPORT THERAPEUTICS, INC. 2025-07-17 US disclosed
WO-2025128873-A1 HETEROCYCLIC PYRIDINONE COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE VIGIL NEUROSCIENCE, INC. (US) 2025-06-19 WO disclosed
WO-2025128848-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE VIGIL NEUROSCIENCE, INC. (US) 2025-06-19 WO disclosed
US-12304908-B2 Azabenzimidazoles and their use as AMPA receptor modulators RAPPORT THERAPEUTICS, INC. (US) 2025-05-20 US disclosed
US-4822794-A Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses RORER PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed
WO-1988008705-A1 PYRIDOOXAZINONE-PYRIDONE COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1988-11-17 WO disclosed
EP-0227932-A1 Novel fused pyridine compounds, intermediates for the preparation of, and use of said compounds as herbicidal agents AMERICAN CYANAMID COMPANY (US) 1987-07-08 EP disclosed
US-4187194-A Encapsulation process XEROX CORPORATION (US) 1980-02-05 US disclosed
US-4097404-A POLYMERIZATION, COACERVATION XEROX CORPORATION (US) 1978-06-27 US disclosed
US-4077804-A Method of producing toner particles by in-situ polymerization and imaging process XEROX CORPORATION (US) 1978-03-07 US disclosed
US-4016099-A DROWNING A DISPERSION TO EFFECT PHASE-SEPARATION XEROX CORPORATION (US) 1977-04-05 US disclosed